Andrea Park
About Andrea Park
Andrea Park is the Director of Business Development and M&A Analytics at BeiGene in the San Francisco Bay Area, with a background in strategy, consulting, venture capital, and investment banking.
Current Role at BeiGene
Andrea Park currently serves as the Director of Business Development and M&A Analytics at BeiGene in the San Francisco Bay Area. In this role, Andrea is involved in shaping and analyzing merger and acquisition strategies, contributing to the company's growth through data-driven decision-making in the biotech sector.
Previous Experience at BeiGene
From 2021 to 2023, Andrea Park served at BeiGene as Chief of Staff to the Chief Business Executive, where she also held the title of Associate Director, Strategy & Partnering Operations. During this period, Andrea focused on strategic partnerships and operational initiatives, playing a key role in the company's business development efforts.
Consulting Experience at Bain & Company
Andrea Park worked as a Consultant at Bain & Company from 2019 to 2021 in the San Francisco Bay Area. She also gained experience as a Summer Associate in 2018. Her tenure at Bain involved providing strategic consulting services to various clients, leveraging her expertise in business development and operations.
Venture Capital Experience
Andrea Park was a Venture Capital Analyst at New Leaf Venture Partners from 2015 to 2017 in the Greater New York City Area. In this role, she conducted market research and investment analysis, contributing to the identification and evaluation of potential investment opportunities in the healthcare sector.
Investment Banking Background
Andrea Park began her career as an Investment Banking Analyst at Bank of America Merrill Lynch, where she worked from 2013 to 2015. She also completed a summer analyst position at the same firm in 2012. During her tenure, she gained valuable experience in financial analysis, deal execution, and client advisory services.
Educational Background
Andrea Park holds a Master of Business Administration (MBA) in Health Care Management from The Wharton School, where she studied from 2017 to 2019. She also earned a Bachelor of Science (BS) in Materials Science and Engineering from the Massachusetts Institute of Technology (MIT). These academic credentials underpin her expertise in business development and M&A analytics.